In vitro combination therapy of pathologic angiogenesis using anti-vascular endothelial growth factor and anti-neuropilin-1 nanobodies

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 314

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-23-10_013

تاریخ نمایه سازی: 19 دی 1399

چکیده مقاله:

Objective(s): Emergence of resistant tumor cells to the current therapeutics is the main hindrance in cancer treatment. Combination therapy, which mixes two or more drugs, is a way to overcome resistant problems of cancer cells to current treatments.  Nanobodies are promising tools in cancer therapy due to their high affinity as well as high penetration to tumor sites. Materials and Methods: Here, the inhibitory effect of mixtures of two nanobodies (anti-vascular endothelial growth factor (VEGF) and anti-neuropilin-1 (NRP-1) nanobodies) on tube formation of human endothelial cells in vitro and ex vivo were analyzed.Results: Results showed that combination of two drugs significantly inhibited proliferation and tube formation of human endothelial cells. In addition, mixtures of two nanobodies inhibited angiogenesis in chick chorioallantoic membrane (CAM) assay efficiently compared with each individual nanobody. Conclusion: Results highlight the efficacy of combination therapy of cancer compared with mono-therapy and promises development of novel anti-cancer therapeutics based on nanobodies targeting two or more targets of tumor cells.

کلیدواژه ها:

Cancer Dual targeting Nanobody NRP ، 1 Single domain antibody VEGF

نویسندگان

Nastaran Mohseni

Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran

Reyhaneh Roshan

Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran

Shamsi Naderi

Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran

Mahdi Behdani

Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran

Fatemeh Kazemi-Lomedasht

Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • 1. Roy H, Bhardwaj S, Ylä-Herttuala S. Biology of vascular ...
  • 2. Shibuya M. Vascular endothelial growth factor and its receptor ...
  • 3. Wise LM, Veikkola T, Mercer AA, Savory LJ, Fleming ...
  • 4. Zachary I, Gliki G. Signaling transduction mechanisms mediating biological ...
  • 5. Ferrara N, Gerber H-P, LeCouter J. The biology of ...
  • 6. Lampropoulou A, Ruhrberg C. Neuropilin regulation of angiogenesis. Bioch ...
  • 7. Gelfand MV, Hagan N, Tata A, Oh W-J, Lacoste ...
  • 8. Lichtenberger BM, Tan PK, Niederleithner H, Ferrara N, Petzelbauer ...
  • 9. Barr MP, Byrne AM, Duffy AM, Condron CM, Devocelle ...
  • 10. Hamerlik P, Lathia JD, Rasmussen R, Wu Q, Bartkova ...
  • 11. Pan Q, Chanthery Y, Liang W-C, Stawicki S, Mak ...
  • 12. Kazemi-Lomedasht F, Behdani M, Bagheri KP, Habibi-Anbouhi M, Abolhassani ...
  • 13. Kazemi-Lomedasht F, Muyldermans S, Habibi-Anbouhi M, Behdani M. Design ...
  • 14. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. ...
  • 15. Hu C, Jiang X. Role of NRP-1 in VEGF-VEGFR2-independent ...
  • 16. Pellet-Many C, Frankel P, Jia H, Zachary I. Neuropilins: ...
  • 17. Rosenfeld PJ, Shapiro H, Tuomi L, Webster M, Elledge ...
  • 18. Schmidinger G, Maar N, Bolz M, Scholda C, Schmidt-Erfurth ...
  • 19. Raimondi C, Fantin A, Lampropoulou A, Denti L, Chikh ...
  • 20. Prud’homme GJ, Glinka Y. Neuropilins are multifunctional coreceptors involved ...
  • 21. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun ...
  • 22. Fuh G, Garcia KC, de Vos AM. The interaction ...
  • 23. Soker S, Gollamudi-Payne S, Fidder H, Charmahelli H, Klagsbrun ...
  • 24. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun ...
  • 25. Cebe-Suarez S, Zehnder-Fjällman A, Ballmer-Hofer K. The role of ...
  • 26. Rajabi M, Mousa SA. The role of angiogenesis in ...
  • 27.Mokhtari RB, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, ...
  • 28. Alirahimi E, Ashkiyan A, Kazemi-Lomedasht F, Azadmanesh K, Hosseininejad-Chafi ...
  • 29. Al-Abd AM, Alamoudi AJ, Abdel-Naim AB, Neamatallah TA, Ashour ...
  • 30. Zirlik K, Duyster J. Anti-angiogenics: current situation and future ...
  • 31. Geretti E, van Meeteren LA, Shimizu A, Dudley AC, ...
  • 32. Bachelder RE, Crago A, Chung J, Wendt MA, Shaw ...
  • نمایش کامل مراجع